SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT

                       Pursuant to Section 13 or 15(d) of
                       the Securities Exchange Act of 1934

                         Date of Report: March 30, 2007
                        (Date of earliest event reported)

                                VASOMEDICAL, INC.
             (Exact name of registrant as specified in its charter)


    Delaware                       0-18105                     11-2871434
--------------------------------------------------------------------------------
(State or other                  (Commission                  (IRS Employer
 jurisdiction of                 File Number)                 Identification
incorporation)                                                    Number)


180 Linden Avenue, Westbury, New York                             11590
-------------------------------------                             -----
(Address of principal executive offices)                       (Zip Code)



Registrant's telephone number including area code             (516) 997-4600
                                                              --------------


                                 Not applicable
                                 --------------
          (Former name or former address, if changed since last report)

Check  the  appropriate  box  below  if the  Form  8-K  filing  is  intended  to
simultaneously  satisfy the filing obligation of the registrant under any of the
following provisions:

[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)

[ ] Soliciting  material  pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)

[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange
Act (17 CFR 240.14d-2(b)

[ ] Pre-commencement  communications  pursuant to Rule 13e-4c under the Exchange
Act (17 CFR 240.13e-4c)





Item 5.02  Departure of Directors or Certain  Officers;  Election of  Directors;
           Appointment of Certain Officers; Compensatory Arrangements of Certain
           officers.

     (b) (i) Effective  March 30, 2007, the Company's Vice  President,  Clinical
and Regulatory and Quality Affairs, Thomas Varricchione,  resigned as an officer
of the Company concurrently with the termination of his employment.

     (ii) On March 30, 2007, the Company received  notification  from Kenneth W.
Rind that he was resigning as a director of the Company,  effective immediately.
His resignation was for personal reasons and not as a result of any disagreement
with the Company.


                                   SIGNATURES

     Pursuant to the  requirements  of the  Securities  Exchange Act of 1934, as
amended,  the  Registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.

                                      VASOMEDICAL, INC.


                                      By: /s/ Thomas Glover
                                          -------------------------------------
                                          Thomas Glover
                                          President and Chief Executive Officer


Dated:   April 4, 2007